» Articles » PMID: 18458649

Predictors of Severe Sepsis Not Clinically Apparent During the First Twenty-four Hours of Hospitalization in Children with Cancer, Neutropenia, and Fever: a Prospective, Multicenter Trial

Abstract

Background: Severe sepsis is not clinically apparent during the first 24 hours of hospitalization in most children with cancer and febrile neutropenia (FN), delaying targeted interventions that could impact mortality. The aim of this study was to prospectively evaluate biomarkers obtained within 24 hours of hospitalization as predictors of severe sepsis before it becomes clinically evident.

Methods: Children with cancer, admitted with FN at high risk for an invasive bacterial infection in 6 public hospitals in Santiago, Chile, were monitored throughout their clinical course for occurrence of severe sepsis. Clinical, demographic and 6 biomarkers [eg, blood urea nitrogen, serum glucose, lactic dehydrogenase, serum C-reactive protein (CRP), interleukin (IL)-8, and procalcitonin] were obtained at the time of admission and after 24 hours. Biomarkers independently associated with severe sepsis diagnosed after the first 24 hours of hospitalization were identified by logistic regression analysis.

Results: A total of 601 high risk FN episodes were enrolled between June 2004 and October 2006; 151 (25%) developed severe sepsis of which 116 (77%) were not clinically apparent during the first 24 hours of hospitalization. Risk factors for severe sepsis were age > or =12 years [odds ratio (OR): 3.85; 95% confidence interval (CI): 2.41-6.15], admission CRP > or =90 mg/L (OR: 2.03; 95% CI: 1.32-3.14), admission IL-8 > or =200 pg/mL (OR: 2.39; 95% CI: 1.51-3.78), 24-hour CRP > or =100 mg/L (OR: 3.06; 95% CI: 1.94-4.85), and 24-hour IL-8 > or =300 pg/mL (OR: 3.13; 95% CI 1.92-5.08).

Conclusions: Age > or =12 years and admission or 24-hour values of CRP > or =90/100 mg/L and IL-8 > or =200/300 pg/mL are predictors of sepsis not clinically apparent during the first 24 hours of hospitalization.

Citing Articles

Serum lactate is associated with increased illness severity in immunocompromised pediatric hematology oncology patients presenting to the emergency department with fever.

Slatnick L, Miller K, Scott H, Loi M, Esbenshade A, Franklin A Front Oncol. 2022; 12:990279.

PMID: 36276165 PMC: 9583361. DOI: 10.3389/fonc.2022.990279.


A Dynamic Approach for Early Risk Prediction of Gram-Negative Bloodstream Infection and Systemic Inflammatory Response Syndrome in Febrile Pediatric Hemato-Oncology Patients.

Rubio J, Palomo Moraleda P, de Lucio Delgado A, Solis Sanchez G, Garcia B, Rey Galan C Children (Basel). 2022; 9(6).

PMID: 35740770 PMC: 9222073. DOI: 10.3390/children9060833.


Biomarkers for Diagnosing Febrile Illness in Immunocompromised Children: A Systematic Review of the Literature.

van der Velden F, Gennery A, Emonts M Front Pediatr. 2022; 10:828569.

PMID: 35372147 PMC: 8965604. DOI: 10.3389/fped.2022.828569.


Pleuro-pulmonary ultrasound in the diagnosis and follow-up of lung infections in children with cancer: a pilot study.

Meli M, La Spina M, Lo Nigro L, Trobia G, Russo G, Di Cataldo A J Ultrasound. 2022; 25(4):865-875.

PMID: 35262851 PMC: 8905564. DOI: 10.1007/s40477-021-00650-3.


Prospective cohort study of the predictive value of inflammatory biomarkers over clinical variables in children and young people with cancer presenting with fever and neutropenia.

Phillips B F1000Res. 2022; 10:1070.

PMID: 35211295 PMC: 8831847. DOI: 10.12688/f1000research.73075.2.